Back to Browse Journals » Clinical Interventions in Aging » Volume 3 » Issue 2

Clinical challenges in the management of osteoporosis

Authors Sheryl F Vondracek, Paul Minne, Michael T McDermott

Published Date June 2008 Volume 2008:3(2) Pages 315—329

DOI http://dx.doi.org/10.2147/CIA.S2539

Published 30 June 2008

Sheryl F Vondracek1, Paul Minne2, Michael T McDermott3

1Department of Clinical Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA; 2Amgen Medical Affairs, Denver, CO, USA; 3Director of the Endocrine and Diabetes Practice, Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA

Abstract: While knowledge regarding the diagnosis and treatment of osteoporosis has expanded dramatically over the last few years, gaps in knowledge still exist with guidance lacking on the appropriate management of several common clinical scenarios. This article uses fictional clinical scenarios to help answer three challenging questions commonly encountered in clinical practice. The first clinical challenge is when to initiate drug therapy in a patient with low bone density. It is estimated that 34 million Americans have low bone density and are at a higher risk for low trauma fractures. Limitations of using bone mineral density alone for drug therapy decisions, absolute risk assessment and evidence for the cost-effectiveness of therapy in this population are presented. The second clinical challenge is the prevention and treatment of vitamin D deficiency. Appropriate definitions for vitamin D insufficiency and deficiency, the populations at risk for low vitamin, potential consequences of low vitamin D, and how to manage a patient with low vitamin D are reviewed. The third clinical challenge is how to manage a patient receiving drug therapy for osteoporosis who has been deemed a potential treatment failure. How to define treatment failure, common causes of treatment failure, and the approach to the management of a patient who is not responding to appropriate osteoporosis therapy are discussed.

Keywords: osteoporosis, osteopenia, bisphosphonate, vitamin D, dual-energy X-ray absorptiometry

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease

Sheryl F Vondracek, Norbert F Voelkel, Michael T McDermott, Connie Valdez

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:267-277

Published Date: 13 July 2009

Readers of this article also read:

Single event-related changes in cerebral oxygenated hemoglobin using word game in schizophrenia

Fujiki R, Morita K, Sato M, Yamashita Y, Kato Y, Ishii Y, Shoji Y, Uchimura N

Neuropsychiatric Disease and Treatment 2014, 10:2353-2360

Published Date: 11 December 2014

Retrospective study of recession of four horizontal rectus muscle in periodic alternating nystagmus

Mimura O, Ishikawa H, Kimura N, Kimura A, Borlongan CV

Clinical Ophthalmology 2014, 8:2523-2528

Published Date: 11 December 2014

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]

Soosay Raj TA, Smith AM, Moore AS

International Journal of Nanomedicine 2013, 8:4705-4706

Published Date: 5 December 2013

Bimatoprost ophthalmic solution 0.03% lowered intraocularpressure of normal-tension glaucoma with minimal adverse events [Corrigendum]

Tsumura T, Yoshikawa K, Suzumura H, Kimura T, Sasaki S, Kimura I, Takeda R

Clinical Ophthalmology 2013, 7:1363-1364

Published Date: 4 July 2013

Opaque intraocular lens implantation

Yusuf IH, Patel CK

Clinical Ophthalmology 2013, 7:489-493

Published Date: 8 March 2013

Topical azithromycin or ofloxacin for endophthalmitis

Stewart MW, Stewart ML

Clinical Ophthalmology 2013, 7:35-38

Published Date: 31 December 2012

Corrigendum

Schneider EW, Johnson MW

Clinical Ophthalmology 2011, 5:1315-1316

Published Date: 16 September 2011